Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 7 studies | 59% ± 30% | |
| type B pancreatic cell | 3 studies | 37% ± 12% | |
| connective tissue cell | 3 studies | 51% ± 24% | |
| abnormal cell | 3 studies | 36% ± 18% | |
| endothelial cell | 3 studies | 24% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| placenta | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 103734.14 | 258 / 258 | 100% | 5694.54 | 229 / 230 |
| pancreas | 97% | 926.41 | 319 / 328 | 48% | 22.16 | 86 / 178 |
| ovary | 99% | 21070.06 | 179 / 180 | 29% | 31.66 | 125 / 430 |
| muscle | 67% | 410.79 | 535 / 803 | 0% | 0 | 0 / 0 |
| breast | 52% | 615.37 | 239 / 459 | 6% | 15.55 | 68 / 1118 |
| heart | 47% | 895.98 | 405 / 861 | 0% | 0 | 0 / 0 |
| uterus | 21% | 133.88 | 36 / 170 | 12% | 60.86 | 57 / 459 |
| liver | 13% | 59.88 | 29 / 226 | 17% | 100.11 | 67 / 406 |
| brain | 19% | 591.05 | 501 / 2642 | 7% | 3.22 | 51 / 705 |
| bladder | 14% | 60.33 | 3 / 21 | 2% | 8.50 | 10 / 504 |
| stomach | 12% | 54.51 | 43 / 359 | 3% | 33.22 | 8 / 286 |
| skin | 6% | 47.81 | 105 / 1809 | 7% | 10.76 | 33 / 472 |
| prostate | 8% | 34.86 | 19 / 245 | 2% | 0.22 | 12 / 502 |
| lung | 2% | 6.68 | 10 / 578 | 7% | 11.67 | 84 / 1155 |
| kidney | 8% | 17.72 | 7 / 89 | 1% | 2.49 | 9 / 901 |
| esophagus | 6% | 20.10 | 89 / 1445 | 2% | 0.11 | 4 / 183 |
| spleen | 8% | 29.41 | 19 / 241 | 0% | 0 | 0 / 0 |
| thymus | 2% | 14.32 | 10 / 653 | 5% | 1.96 | 30 / 605 |
| intestine | 1% | 3.08 | 12 / 966 | 3% | 0.79 | 17 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 3.96 | 2 / 45 |
| adipose | 2% | 15.40 | 24 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 14.25 | 20 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 3.20 | 9 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045746 | Biological process | negative regulation of Notch signaling pathway |
| GO_0030154 | Biological process | cell differentiation |
| GO_0005615 | Cellular component | extracellular space |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | DLK1 |
| Protein name | Delta-like 1 Protein delta homolog 1 (DLK-1) (pG2) [Cleaved into: Fetal antigen 1 (FA1)] Brevideltin Delta-like 1 homolog (Drosophila) Delta like non-canonical Notch ligand 1 Secredeltin |
| Synonyms | DLK |
| Description | FUNCTION: May have a role in neuroendocrine differentiation. |
| Accessions | ENST00000392848.9 Q4U3E1 Q45KX0 P80370 ENST00000331224.10 [P80370-2] G3V2R7 Q0H2C6 G3XAH5 ENST00000556051.1 ENST00000341267.9 [P80370-1] Q969Y6 |
